US Patent Issued to NOVARTIS PHARMACEUTICALS UK on Sept. 8 for "Complement factor I and complement factor I cofactor, vectors encoding therefor and therapeutic use" (British Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,171, issued on Sept. 8, was assigned to NOVARTIS PHARMACEUTICALS UK Ltd. (London).

"Complement factor I and complement factor I cofactor, vectors encoding therefor and therapeutic use" was invented by Anna Dreismann (Stevenage, Great Britain), Scott Ellis (Stevenage, Great Britain) and Josephine Heather Lucienne Joel (Stevenage, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A product comprising (i) a Complement Factor I (CFI) cofactor; and (ii) Complement Factor I (CFI), or nucleotide sequences encoding therefor, as a combined preparation for simultaneous, separate or sequential use in therapy."

The patent was filed on Dec. 23, 2019,...